Lüscher, T.F.; Bax, J.J.; Dedecke, S.; Gersh, B.J.; Hindricks, G.; Huggler, J.; Landmesser, U.; Meier, A.; Rogers, S.; Ruschitzka, F.;
et al. The EHJ’s New Impact Factor is 15.2–Surpassing Circulation and Solid No. 2 Worldwide. Cardiovasc. Med. 2015, 18, 231.
https://doi.org/10.4414/cvm.2015.00349
AMA Style
Lüscher TF, Bax JJ, Dedecke S, Gersh BJ, Hindricks G, Huggler J, Landmesser U, Meier A, Rogers S, Ruschitzka F,
et al. The EHJ’s New Impact Factor is 15.2–Surpassing Circulation and Solid No. 2 Worldwide. Cardiovascular Medicine. 2015; 18(7-8):231.
https://doi.org/10.4414/cvm.2015.00349
Chicago/Turabian Style
Lüscher, Thomas F., Jeroen J. Bax, Suzanne Dedecke, Bernard J. Gersh, Gerhard Hindricks, Johanna Huggler, Ulf Landmesser, Amelia Meier, Sam Rogers, Frank Ruschitzka,
and et al. 2015. "The EHJ’s New Impact Factor is 15.2–Surpassing Circulation and Solid No. 2 Worldwide" Cardiovascular Medicine 18, no. 7-8: 231.
https://doi.org/10.4414/cvm.2015.00349
APA Style
Lüscher, T. F., Bax, J. J., Dedecke, S., Gersh, B. J., Hindricks, G., Huggler, J., Landmesser, U., Meier, A., Rogers, S., Ruschitzka, F., & Wijns, W.
(2015). The EHJ’s New Impact Factor is 15.2–Surpassing Circulation and Solid No. 2 Worldwide. Cardiovascular Medicine, 18(7-8), 231.
https://doi.org/10.4414/cvm.2015.00349
